xanthenes has been researched along with Pigmentary Retinopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flannery, JG; Gregory-Evans, CY; Gregory-Evans, K; Guerin, K; Hodges, MD; Mackay, DS; Moosajee, M | 1 |
| Bringmann, A; Dukic-Stefanovic, S; Hollborn, M; Kohen, L; Limb, GA; Reichenbach, A; Rillich, K; Ulbricht, E; Wagner, L; Wiedemann, P; Wurm, A | 1 |
2 other study(ies) available for xanthenes and Pigmentary Retinopathy
| Article | Year |
|---|---|
Systemic aminoglycoside treatment in rodent models of retinitis pigmentosa.
Topics: Aminoglycosides; Animals; Carrier Proteins; cis-trans-Isomerases; Codon, Nonsense; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroretinography; Eye Proteins; Fluorescent Dyes; Gentamicins; Mice; Mice, Mutant Strains; Rats; Rats, Transgenic; Retina; Retinitis Pigmentosa; Rhodopsin; Xanthenes | 2008 |
The human Müller cell line MIO-M1 expresses opsins.
Topics: Aniline Compounds; Blotting, Western; Calcium; Cell Line; Gene Expression; Humans; Immunohistochemistry; Light; Opsins; Retina; Retinitis Pigmentosa; RNA, Messenger; Xanthenes | 2011 |